Ass. Prof. Mag. Andrea De Luna, Ph.D.

Danube University Krems

Andrea De Luna

Ass. Prof. Mag. Andrea De Luna, Ph.D.

Center for Regenerative Medicine

Projects (Extract Research Database)

Publications (Extract Research Database)

Otahal, A.; Kramer, K.; Kuten-Pella, O.; Weiss, R.; Stotter, C.; Lacza, Z.; Weber, V.; Nehrer, S.; De Luna, A. (2020). Characterization and Chondroprotective Effects of Extracellular Vesicles From Plasma- and Serum-Based Autologous Blood-Derived Products for Osteoarthritis Therapy. Frontiers in Bioenfineering and Biotechnology, Volume 8: 10.3389/fbioe.2020.584050

Kuten, O.; Simon, M.; Hornyák, I.; De Luna-Preitschopf, A.; Nehrer, S.; Lacza, Z. (2018). The Effects of Hyperacute Serum on Adipogenesis and Cell Proliferation of Mesenchymal Stromal Cells. Tissue Engineering Part A, Vol. 24, No. 11-12: doi: 10.1089/ten.TEA.2017.0384

De Luna-Preitschopf, A.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2017). Rapamycin Maintains the Chondrocytic Phenotype and Interferes with Inflammatory Cytokine Induced Processes. International Journal of Molecular Sciences, 18(7): doi:10.3390/ijms18071494

Preitschopf, A.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Zwickl, H.; Rosner, M.; Joó, J.G.; Nehrer, S; Hengstschläger, M; Mikula, M. (2016). Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Stem Cells Translational Medicine: 580-90

Schörghofer, D.; Kinslechner, K.; Preitschopf, A.; Schütz, B.; Röhrl, C.; Hengstschläger, M.; Stangl, H.; Mikula, M. (2015). The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence . Reprod Biol Endocrinol, Vol. 13, No. 88

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transplantation Immunology: 45-50

Üstün, S.; Lassnig, C.; Preitschopf, A.; Mikula, M.; Müller, M.; Hengstschläger, M.; Weichhart, T. (2015). Effects of the mTOR inhibitor everolimus and the PI3K/mTOR inhibitor NVP-BEZ235 in murine acute lung injury models. Transpl Immunol.

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joo, G.J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances Sox9 Expression during Chondrogenic Differentiation of Amniotic Fluid Stem Cells. Tissue Engineering Part A, September 2015, Volume 21, Supplement 1: 192

Preitschopf, A.; Zwickl, H.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Rosner, M.; Joó, J.; Hengstschläger, M.; Nehrer, S.; Mikula, M. (2015). Rapamycin enhances SOX9 expression during chondrogenic differentiation of amniotic fluid stem cells. Tissue Engineering Part A: 192-93

Preitschopf, A.; Li, K.; Schörghofer, D.; Kinslechner, K.; Schütz, B.; Thi Thanh Pham, H.; Rosner, M.; Joo, G.; Röhrl, C.; Weichhart, T.; Stangl, H.; Lubec, G.; Hengstschläger, M.; Mikula, M. (2014). mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. Plos One

Preitschopf, A.; Busch, J.; Zwickl, H.; Nehrer, S.; Hengstschläger, M.; Mikula, M. (2014). Amniotic Fluid Stem Cells for the Treatment of Articular Cartilage Defects. In: Perinatal Stem Cells: 87-98, Springer Verlag

Preitschopf, A.; Zwickl, H.; Li, K.; Lubec, G.; Joo, G.; Rosner, M.; Hengstschläger, M.; Mikula, M. (2012). Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy. Stemm Cell Reviews: 1267-74

Rosner, M.; Mikula, M.; Preitschopf, A.; Feichtinger, M.; Schipany, K.; Hengstschläger, M. (2012). Neurogenic differentiation of amniotic fluid stem cells. Amino Acids: 1591-6

Lectures (Extract Research Database)

Effects of extracellular vesicles from blood derivatives on osteoarthritic chondrocytes

ASEV/GSEV Joint Meeting, Freising, Deutschland, 28/11/2019

Anti-coagulation influences properties of extracellular vesicles isolated from autologous blood derived products used for cartilage repair

World Congress of the International cartilage repair and joint preservation society, Vancouver, Kanada, 08/10/2019

Current Trends in Regenerative Medicine and Tissue Engineering

BioArt Meeting, Krems, Österreich, 03/06/2019

Coagulation influences properties of extracellular vesicles isolated from autologous blood derived products

TERMIS EU Chapter, Rhodos, Griechenland, 28/05/2019

Blood derived products contain extracellular vesicles with distinct biological properties for regenerative approaches

Word Congress of the International Society of Extracellular Vesicles (ISEV), Kyoto, Japan, 25/04/2019

Die Rolle von extrazellulärem Vesikeln aus Blutprodukten in der Osteoarthrose

Technopol Frühstück, Krems,Österreich, 20/03/2019

Different production technology of blood derived products influences differentiation pathway of various cell populations

World Congress of the International Society of Tissue Engineering and Regenerative Medicine (TERMIS), Kyoto, Japan, 07/09/2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

Gordon Research Conference on Extracellular Vesicles, Newry, USA, 21/08/2018

Different production technology of blood derived products influences differentiation pathway of various cell populations

14. World congress of the International cartilage repair society (ICRS) , Macau, China, 12/04/2018

Inhibierung des mTORC1 Signalweges erhält den chondrogenen Phönotyp von OA Chondrozyten

32. Jahreskongress der GOTS, 24/06/2017

Rapamycin preserves the chondrogenic phenotype and supresses cartilage degrading and inflammatory processes in Osteoarthritis

OARSI 2017 World Congress, 28/04/2017

Strategies for Cartilage Regeneration

14. International Life Science Meeting Krems, 05/04/2017

Rapamycin-Induced Hypoxia Inducible Factor 2A Is Essential for Chondrogenic Differentiation of Amniotic Fluid Stem Cells

Osteoarthritis Research Society International World Congress - Amsterdam, Netherlands, 01/04/2016

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Österreichische Gesellschaft für Orthopädie - Vienna,Austria, 30/10/2015

The role of the mTOR pathway on the chondrogenic differentiation of human amniotic fluid stem cells

Tissue Engineering and regenerative Medicine International Society World Kongress - Boston, USA, 11/09/2015

Rapamycin enhances Sox9 expression during chondrogenic differentiation of amniotic fluid stem cells

4th TERMIS World Congress, Boston, USA, 08/09/2015

The effect of Rapamycin on Osteoarthritic Chondrocytes

12th World Congress of the International Cartilage Repair Society (ICRS), Chicago, USA, 11/05/2015

The Role of the mTOR pathway on osteoarthritic chondrocytes

World congress of the International Cartilage Repair Society - Chicago,USA, 08/05/2015

The Role of the mTOR pathway on osteoarthritic chondrocytes

Life Science Meeting - Krems,Austria, 09/04/2015

Chondrogenic differentiation of human amniotic fluid stem cells

Young Scientist Association Symposium-Vienna,Austria, 12/06/2014

Load more
from
Back to top

 

To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems, as well Google Maps for the use of depicting maps. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies and Google Maps. More information concerning privacy policy and data protection official.

OK